Science ❯ Biotechnology

RNA Technology

Therapeutics Gene Delivery Systems Vaccine Technology Therapeutic Innovations Gene Therapy

Eli Lilly to Acquire Orna Therapeutics in Up to $2.4 Billion Bet on In Vivo CAR‑T

The deal gives Lilly Orna’s circular RNA–LNP platform to generate cell therapies inside patients.

Novartis Licenses Arrowhead’s RNAi Parkinson’s Drug in Deal Worth Up to $2.2 Billion